| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 182,
Authors: 704,
Journals: 100,
Outer References: 5958,
Words: 737
Collection span: 2003 - 2005
View: Overview. Sorted by year, source, volume, issue, page.
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 1 | 17 | 1 2003 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 312 (4): 1220-1225 Sioud M; Sorensen DR Cationic liposome-mediated delivery of siRNAs in adult mice | 3 | 9 |
| 2 | 1 | 71 | 2 2003 CURRENT OPINION IN INFECTIOUS DISEASES 16 (6): 593-600 Godfrey A; Laman H; Boshoff C RNA interference: a potential tool against Kaposi's sarcoma-associated herpesvirus | 1 | 3 |
| 3 | 1 | 40 | 3 2003 FASEB JOURNAL 17 (15) Baudhuin LM; Jiang Y; Zaslavsky A; Ishii I; Chun J; et al. S1P(3)-mediated Akt activation and crosstalk with platelet-derived growth factor receptor (PDGFR) | 0 | 0 |
| 4 | 1 | 38 | 4 2003 LANCET 362 (9393): 1401-1403 Wall NR; Shi Y Small RNA: can RNA interference be exploited for therapy? | 7 | 38 |
| 5 | 1 | 100 | 5 2003 NATURE BIOTECHNOLOGY 21 (12): 1457-1465 Scherer LJ; Rossi JJ Approaches for the sequence-specific knockdown of mRNA | 11 | 43 |
| 6 | 1 | 41 | 6 2003 NATURE BIOTECHNOLOGY 21 (12): 1473-1479 Zeytun A; Jeromin A; Scalettar BA; Waldo GS; Bradbury ARM Fluorobodies combine GFP fluorescence with the binding characteristics of antibodies | 0 | 12 |
| 7 | 1 | 15 | 7 2003 NATURE CELL BIOLOGY 5 (9): 771-772 Moss EG; Taylor JM Small-interfering RNAs in the radar of the interferon system | 8 | 10 |
| 8 | 0 | 23 | 8 2003 NATURE CELL BIOLOGY 5 (9): 834-839 Sledz CA; Holko M; de Veer MJ; Silverman RH; Williams BRG Activation of the interferon system by short-interfering RNAs | 181 | 181 |
| 9 | 1 | 4 | 9 2003 NATURE REVIEWS DRUG DISCOVERY 2 (10): 763-764 Frantz S Studies reveal potential pitfalls of RNAi | 0 | 4 |
| 10 | 1 | 66 | 10 2003 NATURE REVIEWS IMMUNOLOGY 3 (11): 851-858 Stevenson M Dissecting HIV-1 through RNA interference | 8 | 11 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 11 | 1 | 44 | 11 2003 OLIGONUCLEOTIDES 13 (5): 381-392 Diallo M; Arenz C; Schmitz K; Sandhoff K; Schepers U Long endogenous dsRNAs can induce complete gene silencing in mammalian cells and primary cultures | 0 | 1 |
| 12 | 5 | 103 | 12 2004 AMERICAN JOURNAL OF TRANSPLANTATION 4 (8): 1227-1236 Ichim TE; Li M; Qian H; Popov IA; Rycerz K; et al. RNA interference: A potent tool for gene-specific therapeutics | 0 | 2 |
| 13 | 6 | 117 | 13 2004 ANNALS OF MEDICINE 36 (7): 540-551 Barik S Development of gene-specific double-stranded RNA drugs | 0 | 0 |
| 14 | 1 | 30 | 14 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 315 (4): 1126-1133 Lingor P; Michel U; Scholl U; Bahr M; Kugler S Transfection of "naked" siRNA results in endosomal uptake and metabolic impairment in cultured neurons | 1 | 4 |
| 15 | 1 | 41 | 15 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 317 (4): 1037-1044 Chen SJ; Wang G; Makrigiorgos GM; Price BD Stable siRNA-mediated silencing of ATM alters the transcriptional profile of HeLa cells | 0 | 0 |
| 16 | 2 | 40 | 16 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 321 (1): 247-253 Saetrom P; Snove O A comparison of SiRNA efficacy predictors | 1 | 2 |
| 17 | 4 | 41 | 17 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 325 (3): 769-773 Snove O; Nedland M; Fjeldstad SH; Humberset H; Birkeland OR; et al. Designing effective siRNAs with off target control | 0 | 0 |
| 18 | 1 | 24 | 18 2004 BIOCHEMICAL SOCIETY TRANSACTIONS 32: 355-359 Kaufmann J; Pronk G; Giese K; Klippel A Identification of novel effectors of invasive cell growth downstream of phosphoinositide 3-kinase | 0 | 3 |
| 19 | 3 | 23 | 19 2004 BIOCHEMICAL SOCIETY TRANSACTIONS 32: 952-956 Sledz CA; Williams BRG RNA interference and double-stranded-RNA-activated pathways | 1 | 1 |
| 20 | 1 | 39 | 20 2004 BIOCHEMISTRY 43 (7): 1921-1927 Liu YH; Braasch DA; Nulf CJ; Corey DR Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids | 1 | 7 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 21 | 1 | 43 | 21 2004 BIOCHEMISTRY 43 (42): 13348-13356 Spagnou S; Miller AD; Keller M Lipidic carriers of siRNA: Differences in the formulation, cellular uptake, and delivery with plasmid DNA | 0 | 0 |
| 22 | 1 | 42 | 22 2004 BIOCHIMIE 86 (9-10): 713-721 Kasashima K; Sakota E; Kozu T Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences | 0 | 0 |
| 23 | 1 | 31 | 23 2004 BIOCONJUGATE CHEMISTRY 15 (6): 1481-1487 Metelev V; Weissleder R; Bogdanov A Synthesis and properties of fluorescent NF-kappa B-recognizing hairpin oligodeoxyribonucleotide decoys | 0 | 0 |
| 24 | 1 | 28 | 24 2004 BIOTECHNIQUES 36 (1): 74-+ Kojima SI; Vignjevic D; Borisy GG Improved silencing vector co-expressing GFP and small hairpin RNA | 1 | 2 |
| 25 | 1 | 55 | 25 2004 BMC CANCER 4: Art. No. 44 Martinez N; Drescher B; Riehle H; Cullmann C; Vornlocher HP; et al. The oncogenic fusion protein RUNX1-CBFA2T1 supports proliferation and inhibits senescence in t(8;21)-positive leukaemic cells | 0 | 2 |
| 26 | 1 | 30 | 26 2004 BMC MOLECULAR BIOLOGY 5: Art. No. 9 Fish RJ; Kruithof EKO Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors | 0 | 1 |
| 27 | 1 | 42 | 27 2004 BRAIN RESEARCH PROTOCOLS 13 (2): 115-125 Bhargava A; Dallman MF; Pearce D; Cho SJ Long double-stranded RNA-mediated RNA interference as a tool to achieve site-specific silencing of hypothalamic neuropeptides | 0 | 0 |
| 28 | 1 | 61 | 28 2004 CANCER RESEARCH 64 (5): 1834-1842 Trougakos IP; So A; Jansen B; Gleave ME; Gonos ES Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress | 1 | 11 |
| 29 | 1 | 44 | 29 2004 CANCER RESEARCH 64 (7): 2619-2626 Jia L; Choong CSY; Ricciardelli C; Kim J; Tilley WD; et al. Androgen receptor signaling: Mechanism of interleukin-6 inhibition | 0 | 4 |
| 30 | 1 | 68 | 30 2004 CANCER RESEARCH 64 (11): 4030-4039 Bouker KB; Skaar TC; Fernandez DR; O'Brien KA; Riggins RB; et al. Interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (Faslodex, Fulvestrant) | 0 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 31 | 2 | 45 | 31 2004 CANCER RESEARCH 64 (24): 9144-9151 Malathi K; Paranjape JM; Ganapathi R; Silverman RH HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2 ',5 '-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand | 0 | 0 |
| 32 | 1 | 39 | 32 2004 CELL CYCLE 3 (5): 588-590 Nilsson JA; Cleveland JL Mnt - Master regulator of the Max network | 0 | 0 |
| 33 | 1 | 53 | 33 2004 CELL DEATH AND DIFFERENTIATION 11 (8): 915-923 Chawla-Sarkar M; Bae SI; Reu FJ; Jacobs BS; Lindner DJ; et al. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis | 0 | 2 |
| 34 | 2 | 48 | 34 2004 CELLULAR AND MOLECULAR LIFE SCIENCES 61 (16): 2113-2124 Li Y; Wasser S; Lim SG; Tan TMC Genome-wide expression profiling of RNA interference of hepatitis B virus gene expression and replication | 0 | 0 |
| 35 | 1 | 60 | 35 2004 CELLULAR AND MOLECULAR NEUROBIOLOGY 24 (6): 793-814 Satoh J; Yamamura T Gene expression profile following stable expression of the cellular prion protein | 0 | 0 |
| 36 | 1 | 25 | 36 2004 CHEMBIOCHEM 5 (3): 383-386 Puthenveetil S; Veliz EA; Beal PA Site-specific modification of Epstein-Barr virus-encoded RNA 1 with N-2-benzylguanosine limits the binding sites occupied by PKR | 2 | 2 |
| 37 | 2 | 42 | 37 2004 CHEMISTRY & BIOLOGY 11 (9): 1239-1250 Stephens OM; Haudenschild BL; Beal PA The binding selectivity of ADAR2's dsRBMs contributes to RNA-editing selectivity | 1 | 2 |
| 38 | 1 | 49 | 38 2004 CIRCULATION RESEARCH 94 (6): 743-751 Bruhl T; Urbich C; Aicher D; Acker-Palmer A; Zeiher AM; et al. Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation | 0 | 1 |
| 39 | 1 | 137 | 39 2004 CURRENT MOLECULAR MEDICINE 4 (5): 507-517 Fuchs U; Damm-Welk C; Borkhardt A Silencing of disease-related genes by small interfering RNAs | 0 | 0 |
| 40 | 1 | 65 | 40 2004 CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT 7 (2): 179-187 Kurreck J Antisense and RNA interference approaches to target validation in pain research | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 41 | 1 | 55 | 41 2004 CURRENT OPINION IN GENETICS & DEVELOPMENT 14 (2): 174-180 Schramke V; Allshire R Those interfering little RNAs! Silencing and eliminating chromatin | 0 | 15 |
| 42 | 2 | 64 | 42 2004 CURRENT OPINION IN GENETICS & DEVELOPMENT 14 (5): 470-476 Friedman A; Perrimon N Genome-wide high-throughput screens in functional genomics | 0 | 2 |
| 43 | 1 | 88 | 43 2004 CURRENT OPINION IN MOLECULAR THERAPEUTICS 6 (2): 129-135 Scherr M; Eder M RNAi in functional genomics | 1 | 1 |
| 44 | 2 | 58 | 44 2004 CURRENT OPINION IN MOLECULAR THERAPEUTICS 6 (2): 136-140 Nencioni A; Sandy P; Dillon C; Kissler S; Blume-Jensen P; et al. RNA interference for the identification of disease-associated genes | 0 | 2 |
| 45 | 1 | 41 | 45 2004 CURRENT OPINION IN MOLECULAR THERAPEUTICS 6 (4): 373-380 Boden D; Pusch O; Ramratnam B HIV-1-specific RNA interference | 0 | 0 |
| 46 | 2 | 52 | 46 2004 CURRENT OPINION IN MOLECULAR THERAPEUTICS 6 (5): 546-550 Jones SW; Lindsay MA Overview of target validation and the impact of oligonucleotides | 0 | 0 |
| 47 | 1 | 74 | 47 2004 CURRENT OPINION IN RHEUMATOLOGY 16 (5): 541-547 Crow MK; Kirou KA Interferon-alpha in systemic lupus erythematosus | 0 | 2 |
| 48 | 1 | 114 | 48 2004 CURRENT PHARMACEUTICAL BIOTECHNOLOGY 5 (4): 361-368 Poliseno L; Mercatanti A; Citti L; Rainaldi G RNA-based drugs: From RNA interference to short interfering RNAs | 0 | 0 |
| 49 | 2 | 78 | 49 2004 CYTOGENETIC AND GENOME RESEARCH 105 (2-4): 412-421 Prawitt D; Brixel L; Spangenberg C; Eshkind L; Heck R; et al. RNAi knock-down mice: an emerging technology for post-genomic functional genetics | 1 | 5 |
| 50 | 2 | 108 | 50 2004 CYTOGENETIC AND GENOME RESEARCH 105 (2-4): 422-434 Svoboda P Long dsRNA and silent genes strike back : RNAi in mouse oocytes and early embryos | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 51 | 1 | 49 | 51 2004 CYTOKINE & GROWTH FACTOR REVIEWS 15 (2-3): 97-102 Kiss-Toth E; Qwarnstrom EE; Dower SK Hunting for genes by functional screens | 0 | 0 |
| 52 | 1 | 44 | 52 2004 DEVELOPMENTAL DYNAMICS 230 (2): 299-308 Bron R; Eickholt BJ; Vermeren M; Fragale N; Cohen J Functional knockdown of neuropilin-1 in the developing chick nervous system by siRNA hairpins phenocopies genetic ablation in the mouse | 0 | 2 |
| 53 | 3 | 26 | 53 2004 DEVELOPMENTAL DYNAMICS 231 (3): 592-600 Rao M; Baraban JH; Rajaii F; Sockanathan S In vivo comparative study of RNAi methodologies by in ovo electroporation in the chick embryo | 0 | 0 |
| 54 | 1 | 28 | 54 2004 DIFFERENTIATION 72 (2-3): 103-111 Pebernard S; Iggo RD Determinants of interferon-stimulated gene induction by RNAi vectors | 12 | 14 |
| 55 | 1 | 31 | 55 2004 DNA REPAIR 3 (11): 1469-1474 Polosina YY; Rosenquist TA; Grollman AP; Miller H 'knock down' of DNA polymerase beta by RNA interference: recapitulation of null phenotype | 0 | 0 |
| 56 | 1 | 22 | 56 2004 ENVIRONMENTAL HEALTH PERSPECTIVES 112 (4): A210-A211 Stribinskis V; Ramos KS Decoding the riddle: The dawn of RNAi for the study of gene-gene and gene-environment interactions | 0 | 0 |
| 57 | 1 | 155 | 57 2004 EXPERIMENTAL GERONTOLOGY 39 (7): 985-998 Geley S; Muller C RNAi: ancient mechanism with a promising future | 0 | 0 |
| 58 | 2 | 100 | 58 2004 EXPERT OPINION ON BIOLOGICAL THERAPY 4 (3): 319-327 Devroe E; Silver PA Therapeutic potential of retroviral RNAi vectors | 0 | 6 |
| 59 | 2 | 57 | 59 2004 EXPERT OPINION ON BIOLOGICAL THERAPY 4 (4): 531-542 Ganju P; Hall J Potential applications of siRNA for pain therapy | 0 | 3 |
| 60 | 3 | 71 | 60 2004 EXPERT OPINION ON BIOLOGICAL THERAPY 4 (12): 1921-1929 Borkhardt A; Heidenreich O RNA interference as a potential tool in the treatment of leukaemia | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 61 | 1 | 57 | 61 2004 FEBS LETTERS 560 (1-3): 210-214 Hung L; Kumar V Specific inhibition of gene expression and transactivation functions of hepatitis B virus X protein and c-myc by small interfering RNAs | 0 | 1 |
| 62 | 1 | 33 | 62 2004 FEBS LETTERS 578 (3): 291-296 Boese A; Sommer P; Gaussin A; Reimann A; Nehrbass U Ini1/hSNF5 is dispensable for retrovirus-induced cytoplasmic accumulation of PML and does not interfere with integration | 0 | 0 |
| 63 | 1 | 62 | 63 2004 GASTROENTEROLOGY 127 (4): 1174-1188 Wang XM; Tang XL; Gong XM; Albanis E; Friedman SL; et al. Regulation of hepatic stellate cell activation and growth by transcription factor myocyte enhancer factor 2 | 0 | 1 |
| 64 | 1 | 82 | 64 2004 GENE THERAPY 11 (16): 1241-1248 Caplen NJ Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference | 0 | 3 |
| 65 | 1 | 17 | 65 2004 GENESIS 39 (2): 73-78 Chesnutt C; Niswander L Plasmid-based short-hairpin RNA interference in the chicken embryo | 1 | 3 |
| 66 | 1 | 160 | 66 2004 HUMAN MOLECULAR GENETICS 13: R275-R288 Buckingham SD; Esmaeili B; Wood M; Sattelle DB RNA interference: from model organisms towards therapy for neural and neuromuscular disorders | 0 | 2 |
| 67 | 2 | 128 | 67 2004 IMMUNOLOGICAL REVIEWS 198 (1): 285-303 Lecellier CH; Voinnet O RNA silencing: no mercy for viruses? | 1 | 7 |
| 68 | 1 | 66 | 68 2004 INTERNATIONAL JOURNAL OF CANCER 112 (6): 994-1002 Wang XL; Wang MY; Amarzguioui M; Liu F; Fodstad O; et al. Downregulation of tissue factor by RNA interference in human melanoma Lox-L cells reduces pulmonary metastasis in nude mice | 0 | 0 |
| 69 | 1 | 133 | 69 2004 JOURNAL OF BIOCHEMISTRY 136 (2): 133-147 Shiota M; Sano M; Miyagishi M; Taira K Ribozymes: Applications to functional analysis and gene discovery | 0 | 0 |
| 70 | 1 | 49 | 70 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279 (2): 1123-1131 Li GQ; Xiang Y; Sabapathy K; Silverman RH An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase | 1 | 6 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 71 | 1 | 36 | 71 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279 (2): 1161-1166 Rinehart J; Horn EK; Wei D; Soll D; Schneider A Non-canonical eukaryotic glutaminyl-and glutamyl-tRNA synthetases form mitochondrial aminoacyl-tRNA in Trypanosoma brucei | 0 | 2 |
| 72 | 1 | 43 | 72 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279 (12): 11967-11975 Hattori M; Suzuki AZ; Higo T; Miyauchi H; Michikawa T; et al. Distinct roles of inositol 1,4,5-trisphosphate receptor types 1 and 3 in Ca2+ signaling | 0 | 4 |
| 73 | 1 | 43 | 73 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279 (16): 16178-16184 Ueno T; Linder S; Na CL; Rice WR; Johansson J; et al. Processing of pulmonary surfactant protein B by napsin and cathepsin H | 0 | 1 |
| 74 | 1 | 74 | 74 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279 (43): 45194-45207 Barnes BJ; Richards J; Mancl M; Hanash S; Beretta L; et al. Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection | 0 | 2 |
| 75 | 1 | 33 | 75 2004 JOURNAL OF CELL BIOLOGY 166 (4): 537-548 Treves S; Franzini-Armstrong C; Moccagatta L; Arnoult C; Grasso C; et al. Junctate is a key element in calcium entry induced by activation of InsP(3) receptors and/or calcium store depletion | 0 | 0 |
| 76 | 2 | 166 | 76 2004 JOURNAL OF DRUG TARGETING 12 (6): 315-340 Gilmore IR; Fox SP; Hollins AJ; Muhammad SB; Akhtar S The design and exogenous delivery of siRNA for post-transcriptional gene silencing | 0 | 0 |
| 77 | 1 | 58 | 77 2004 JOURNAL OF GENERAL VIROLOGY 85: 983-991 Bucher E; Hemmes H; de Haan P; Goldbach R; Prins M The influenza A virus NS1 protein binds small interfering RNAs and suppresses RNA silencing in plants | 1 | 4 |
| 78 | 1 | 54 | 78 2004 JOURNAL OF GENERAL VIROLOGY 85: 1371-1379 Chang Y; Chang SS; Lee HH; Doong SL; Takada K; et al. Inhibition of the Epstein-Barr virus lytic cycle by Zta-targeted RNA interference | 1 | 3 |
| 79 | 1 | 28 | 79 2004 JOURNAL OF IMMUNOLOGY 172 (11): 6545-6549 Kariko K; Bhuyan P; Capodici J; Weissman D Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3 | 7 | 11 |
| 80 | 1 | 40 | 80 2004 JOURNAL OF IMMUNOLOGY 173 (7): 4425-4432 Hon H; Rucker EB; Hennighausen L; Jacob J bcl-X-L is critical for dendritic cell survival in vivo | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 81 | 1 | 41 | 81 2004 JOURNAL OF MOLECULAR BIOLOGY 342 (4): 1069-1076 Gibbons DL; Shashikant C; Hayday AC A comparative analysis of RNA targeting strategies in the thymosin beta 4 gene | 0 | 0 |
| 82 | 1 | 28 | 82 2004 JOURNAL OF MOLECULAR BIOLOGY 342 (4): 1077-1083 Zhang HF; Altman S Inhibition of the expression of the human RNase P protein subunits Rpp21, Rpp25, Rpp29 by external guide sequences (EGSs) and siRNA | 0 | 0 |
| 83 | 2 | 69 | 83 2004 JOURNAL OF MOLECULAR ENDOCRINOLOGY 33 (3): 545-557 Bantounas I; Phylactou LA; Uney JB RNA interference and the use of small interfering RNA to study gene function in mammalian systems | 0 | 0 |
| 84 | 1 | 112 | 84 2004 JOURNAL OF NEUROLOGY 251 (4): 491-500 Veldink JH; Van den Berg LH; Wokke JHJ The future of motor neuron disease - The challenge is in the genes | 0 | 0 |
| 85 | 2 | 41 | 85 2004 JOURNAL OF VIROLOGY 78 (12): 6698-6704 Johnson KL; Price BD; Eckerle LD; Ball LA Nodamura virus nonstructural protein B2 can enhance viral RNA accumulation in both mammalian and insect cells | 0 | 1 |
| 86 | 1 | 51 | 86 2004 JOURNAL OF VIROLOGY 78 (17): 8983-8993 Dong BH; Zhou QS; Zhao J; Zhou AM; Harty RN; et al. Phospholipid scramblase 1 potentiates the antiviral activity of interferon | 0 | 1 |
| 87 | 1 | 46 | 87 2004 JOURNAL OF VIROLOGY 78 (19): 10276-10281 Bhuyan PK; Kariko K; Capodici J; Lubinski J; Hook LM; et al. Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes | 0 | 0 |
| 88 | 1 | 58 | 88 2004 JOURNAL OF VIROLOGY 78 (20): 10848-10855 Arrighi JF; Pion M; Wiznerowicz M; Geijtenbeek TB; Garcia E; et al. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells | 0 | 1 |
| 89 | 2 | 41 | 89 2004 JOURNAL OF VIROLOGY 78 (23): 12868-12876 Lu SH; Cullen BR Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and microRNA biogenesis | 1 | 2 |
| 90 | 2 | 43 | 90 2004 LIVER INTERNATIONAL 24 (6): 526-531 Shlomai A; Shaul Y RNA interference - small RNAs effectively fight viral hepatitis | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 91 | 1 | 33 | 91 2004 M S-MEDECINE SCIENCES 20 (8-9): 815-819 Dautry F; Ribet C RNA interference : towards a functional genomics in mammalian cells ? | 0 | 0 |
| 92 | 2 | 77 | 92 2004 MEDICINAL RESEARCH REVIEWS 24 (6): 748-761 Zhou HS; Liu DP; Liang CC Challenges and strategies: The immune responses in gene therapy | 0 | 1 |
| 93 | 1 | 27 | 93 2004 MOLECULAR CANCER THERAPEUTICS 3 (10): 1193-1199 Patry C; Lemieux B; Wellinger RJ; Chabot B Targeting heterogeneous nuclear ribonucleoparticule A1 and A2 proteins by RNA interference promotes cell death in transformed but not in normal mouse cell lines | 0 | 0 |
| 94 | 4 | 101 | 94 2004 NATURE 431 (7006): 371-378 Hannon GJ; Rossi JJ Unlocking the potential of the human genome with RNA interference | 3 | 22 |
| 95 | 1 | 15 | 95 2004 NATURE BIOTECHNOLOGY 22 (3): 280-282 Samuel CE Knockdown by RNAi-proceed with caution | 0 | 2 |
| 96 | 1 | 14 | 96 2004 NATURE BIOTECHNOLOGY 22 (3): 321-325 Kim DH; Longo M; Han Y; Lundberg P; Cantin E; et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase | 18 | 25 |
| 97 | 4 | 69 | 97 2004 NATURE BIOTECHNOLOGY 22 (12): 1533-1537 Agrawal S; Kandimalla ER Antisense and siRNA as agonists of Toll-like receptors | 0 | 1 |
| 98 | 1 | 33 | 98 2004 NATURE BIOTECHNOLOGY 22 (12): 1546-1553 Shen L; Evel-Kabler K; Strube R; Chen SY Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity | 0 | 3 |
| 99 | 2 | 37 | 99 2004 NATURE BIOTECHNOLOGY 22 (12): 1573-1578 Unwalla HJ; Li MJ; Kim JD; Li HT; Ehsani A; et al. Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA | 0 | 0 |
| 100 | 1 | 30 | 100 2004 NATURE CELL BIOLOGY 6 (8): 770-776 Chadee DN; Kyriakis JM MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation | 0 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 101 | 4 | 196 | 101 2004 NATURE REVIEWS DRUG DISCOVERY 3 (4): 318-329 Dorsett Y; Tuschl T siRNAs: Applications in functional genomics and potential as therapeutics | 7 | 35 |
| 102 | 1 | 102 | 102 2004 NATURE REVIEWS GENETICS 5 (3): 190-201 Steinmetz LM; Davis RW Maximizing the potential of functional genomics | 0 | 9 |
| 103 | 3 | 127 | 103 2004 NATURE REVIEWS GENETICS 5 (5): 355-365 Mittal V Improving the efficiency of RNA interference in mammals | 3 | 13 |
| 104 | 1 | 89 | 104 2004 NATURE REVIEWS IMMUNOLOGY 4 (4): 301-308 Abraham RT; Weiss A Timeline - Jurkat T cells and development of the T-cell receptor signalling paradigm | 0 | 8 |
| 105 | 1 | 128 | 105 2004 NATURE REVIEWS MOLECULAR CELL BIOLOGY 5 (12): 1013-1023 Tian B; Bevilacqua PC; Diegelman-Parente A; Mathews MB The double-stranded-RNA-binding motif: Interference and much more | 0 | 1 |
| 106 | 4 | 49 | 106 2004 NEW ENGLAND JOURNAL OF MEDICINE 351 (17): 1772-1777 Stevenson M Therapeutic potential of RNA interference | 0 | 5 |
| 107 | 1 | 20 | 107 2004 NUCLEIC ACIDS RESEARCH 32 (1): Art. No. e3 Kohli M; Rago C; Lengauer C; Kinzler KW; Vogelstein B Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses | 0 | 2 |
| 108 | 3 | 45 | 108 2004 NUCLEIC ACIDS RESEARCH 32 (4): 1469-1479 Pancoska P; Moravek Z; Moll UM Efficient RNA interference depends on global context of the target sequence: quantitative analysis of silencing efficiency using Eulerian graph representation of siRNA | 2 | 6 |
| 109 | 1 | 37 | 109 2004 NUCLEIC ACIDS RESEARCH 32 (10): Art. No. e85 Coumoul X; Li WM; Wang RH; Deng CX Inducible suppression of Fgfr2 and Survivin in ES cells using a combination of the RNA interference (RNAi) and the Cre-LoxP system | 0 | 0 |
| 110 | 1 | 14 | 110 2004 NUCLEIC ACIDS RESEARCH 32 (12): Art. No. e102 Mangeot PE; Cosset FL; Colas P; Mikaelian I A universal transgene silencing method based on RNA interference | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 111 | 1 | 31 | 111 2004 NUCLEIC ACIDS RESEARCH 32 (13): Art. No. e109 Minakuchi Y; Takeshita F; Kosaka N; Sasaki H; Yamamoto Y; et al. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo | 0 | 2 |
| 112 | 1 | 36 | 112 2004 ONCOGENE 23 (42): 7067-7075 Suzuki A; Kusakai G; Kishimoto A; Shimojo Y; Miyamoto S; et al. Regulation of caspase-6 and FLIP by the AMPK family member ARK5 | 0 | 0 |
| 113 | 1 | 58 | 113 2004 ONCOGENE 23 (49): 8105-8117 McManus DC; Lefebvre CA; Cherton-Horvat G; St-Jean M; Kandimalla ER; et al. Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics | 0 | 1 |
| 114 | 1 | 32 | 114 2004 ONCOGENE 23 (51): 8384-8391 Sachse C; Echeverri CJ Oncology studies using siRNA libraries: the dawn of RNAi-based genomics | 0 | 1 |
| 115 | 3 | 62 | 115 2004 ONCOGENE 23 (51): 8392-8400 Willingham AT; Deveraux QL; Hampton GM; Aza-Blanc P RNAi and HTS: exploring cancer by systematic loss-of-function | 0 | 1 |
| 116 | 1 | 13 | 116 2004 PHARMACOGENOMICS 5 (3): 239-242 Jain KK RNAi and siRNA | 0 | 0 |
| 117 | 1 | 81 | 117 2004 PLOS BIOLOGY 2 (4): 465-475 Hutvagner G; Simard MJ; Mello CC; Zamore PD Sequence-specific inhibition of small RNA function | 1 | 4 |
| 118 | 1 | 34 | 118 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101 (1): 245-250 Radu CG; Yang LV; Riedinger M; Au M; Witte ON T cell chemotaxis to lysophosphatidylcholine through the G2A receptor | 0 | 11 |
| 119 | 1 | 48 | 119 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101 (5): 1350-1355 Li WX; Li HW; Lu R; Li F; Dus M; et al. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing | 9 | 26 |
| 120 | 3 | 43 | 120 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101 (23): 8676-8681 Ge Q; Filip L; Bai AL; Nguyen T; Eisen HN; et al. Inhibition of influenza virus production in virus-infected mice by RNA interference | 5 | 16 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 121 | 2 | 36 | 121 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101 (23): 8682-8686 Tompkins SM; Lo CY; Tumpey TM; Epstein SL Protection against lethal influenza virus challenge by RNA interference in vivo | 5 | 12 |
| 122 | 1 | 56 | 122 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101 (25): 9441-9446 Zhang Q; Fukuda M; Van Bockstaele E; Pascual O; Haydon PG Synaptotagmin IV regulates glial glutamate release | 0 | 7 |
| 123 | 1 | 50 | 123 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101 (26): 9578-9583 Chang HM; Paulson M; Holko M; Rice CM; Williams BRG; et al. Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity | 0 | 2 |
| 124 | 1 | 18 | 124 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101 (41): 14883-14888 Hamar P; Song EW; Kokeny G; Chen A; Ouyang NT; et al. Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury | 1 | 4 |
| 125 | 2 | 24 | 125 2004 PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS 31 (7): 590-595 Wang W; Zhu HZ; Xue JL RNAi as a gene therapy approach | 0 | 0 |
| 126 | 1 | 167 | 126 2004 REVIEWS IN MEDICAL VIROLOGY 14 (1): 47-64 Peracchi A Prospects for antiviral ribozymes and deoxyribozymes | 0 | 3 |
| 127 | 2 | 48 | 127 2004 RNA-A PUBLICATION OF THE RNA SOCIETY 10 (12): 1934-1945 Zheng XF; Bevilacqua PC Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tails | 1 | 1 |
| 128 | 4 | 15 | 128 2004 SCIENTIST 18 (6): 32-35 Adams A RNAi inches toward the clinic | 0 | 0 |
| 129 | 2 | 34 | 129 2004 TRENDS IN BIOTECHNOLOGY 22 (8): 390-394 Paroo Z; Corey DR Challenges for RNAi in vivo | 1 | 2 |
| 130 | 1 | 81 | 130 2004 TRENDS IN BIOTECHNOLOGY 22 (9): 463-469 Tang GL; Galili G Using RNAi to improve plant nutritional value: from mechanism to application | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 131 | 2 | 14 | 131 2004 TRENDS IN GENETICS 20 (11): 521-524 Jackson AL; Linsley PS Noise amidst the silence: off-target effects of siRNAs? | 2 | 6 |
| 132 | 3 | 75 | 132 2004 VIROLOGY 323 (2): 173-181 Radhakrishnan SK; Layden TJ; Gartel AL RNA interference as a new strategy against viral hepatitis | 2 | 7 |
| 133 | 1 | 73 | 133 2004 ZEBRAFISH: 2ND EDITION CELLULAR AND DEVELOPMENTAL BIOLOGY 76: 593-612 Dodd A; Chambers SP; Nielsen PE; Love DR Modeling human disease by gene targeting | 0 | 0 |
| 134 | 6 | 114 | 134 2005 ANNUAL REVIEW OF MEDICINE 56: 401-423 Dykxhoorn DM; Lieberman J The silent revolution: RNA interference as basic biology, research tool, and therapeutic | 1 | 1 |
| 135 | 3 | 23 | 135 2005 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 326 (2): 307-312 Michel U; Malik I; Ebert S; Bahr M; Kugler S Long-term in vivo and in vitro AAV-2-mediated RNA interference in rat retinal ganglion cells and cultured primary neurons | 0 | 0 |
| 136 | 1 | 31 | 136 2005 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 328 (4): 1034-1042 Mise-Omata S; Obata Y; Iwase S; Mise N; Doi TS Transient strong reduction of PTEN expression by specific RNAi induces loss of adhesion of the cells | 0 | 0 |
| 137 | 3 | 80 | 137 2005 BLOOD 105 (6): 2510-2518 Godfrey A; Anderson J; Papanastasiou A; Takeuchi Y; Boshoff C Inhibiting primary effusion lymphoma, by lentiviral vectors encoding short hairpin RNA | 0 | 0 |
| 138 | 2 | 114 | 138 2005 CANCER GENE THERAPY 12 (3): 217-227 Izquierdo M Short interfering RNAs as a tool for cancer gene therapy | 0 | 0 |
| 139 | 1 | 53 | 139 2005 CANCER RESEARCH 65 (7): 2592-2601 Li WL; Kessler P; Yeger H; Alami J; Reeve AE; et al. A gene expression signature for relapse of primary Wilms tumors | 0 | 0 |
| 140 | 1 | 48 | 140 2005 CELL DEATH AND DIFFERENTIATION 12 (3): 213-223 Tanno B; Cesi V; Vitali R; Sesti F; Giuffrida ML; et al. Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 141 | 4 | 125 | 141 2005 CHEMBIOCHEM 6 (2): 257-266 Beal PA Duplex RNA-binding enzymes: Headliners from neurobiology, virology, and development | 0 | 0 |
| 142 | 1 | 36 | 142 2005 CHEMBIOCHEM 6 (3): 468-479 Egner U; Kratzschmar J; Kreft B; Pohlenz HD; Schneider M The target discovery process | 0 | 0 |
| 143 | 2 | 82 | 143 2005 CURRENT DRUG TARGETS 6 (1): 21-29 Forte A; Cipollaro M; Cascino A; Galderisi U Small interfering RNAs and antisense oligonucleotides for treatment of neurological diseases | 0 | 0 |
| 144 | 2 | 187 | 144 2005 CURRENT HIV RESEARCH 3 (1): 61-71 Bannwarth S; Gatignol A HIV-1 TAR RNA: The target of molecular interactions between the virus and its host | 0 | 0 |
| 145 | 3 | 109 | 145 2005 CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT 8 (2): 262-269 Scherr M; Eder M Modulation of gene expression by siRNA in hematopoietic cells | 0 | 0 |
| 146 | 1 | 50 | 146 2005 CURRENT OPINION IN PLANT BIOLOGY 8 (2): 216-222 Wang MB; Metzlaff M RNA silencing and antiviral defense in plants | 0 | 0 |
| 147 | 2 | 83 | 147 2005 DRUG DISCOVERY TODAY 10 (3): 205-212 Vanhecke D; Janitz M Functional genomics using high-throughput RNA interference | 0 | 0 |
| 148 | 1 | 78 | 148 2005 DRUG DISCOVERY TODAY 10 (5): 345-352 Kliger Y; Levanon EY; Gerber D From genome to antivirals: SARS as a test tube | 0 | 0 |
| 149 | 2 | 21 | 149 2005 ENDOCRINE-RELATED CANCER 12 (1): 65-73 Nagahata T; Sato T; Tomura A; Onda M; Nishikawa K; et al. Identification of RAI3 as a therapeutic target for breast cancer | 0 | 0 |
| 150 | 3 | 29 | 150 2005 FEBS LETTERS 579 (1): 173-178 Rippmann JF; Schnapp A; Weith A; Hobbie S Gene silencing with STAT6 specific siRNAs blocks eotaxin release in IL-4/TNF alpha stimulated human epithelial cells | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 151 | 2 | 85 | 151 2005 GENE THERAPY 12 (1): 5-11 Ryther RCC; Flynt AS; Phillips JA; Patton JG siRNA therapeutics: Big potential from small RNAs | 1 | 1 |
| 152 | 3 | 45 | 152 2005 GENE THERAPY 12 (3): 246-251 Golzio M; Mazzolini L; Moller P; Rols MP; Teissie J Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery | 0 | 0 |
| 153 | 1 | 36 | 153 2005 GLIA 50 (1): 66-79 Lee JH; Park EJ; Kim OS; Kim HY; Joe EH; et al. Double-stranded RNA-activated protein kinase is required for the LPS-induced activation of STAT1 inflammatory signaling in rat brain glial cells | 0 | 0 |
| 154 | 2 | 26 | 154 2005 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 15 (4): 579-583 Albertin G; Carraro G; Nussdorfer GG Human adrenomedullin gene silencing by short interfering RNAs: A preliminary study | 0 | 0 |
| 155 | 16 | 70 | 155 2005 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 293 (11): 1367-1373 Shankar P; Manjunath N; Lieberman J The prospect of silencing disease using RNA interference | 0 | 0 |
| 156 | 1 | 52 | 156 2005 JOURNAL OF BIOLOGICAL CHEMISTRY 280 (4): 2700-2707 Chen X; Dai JC; Orellana SA; Greenfield EM Endogenous protein kinase inhibitor gamma terminates immediate-early gene expression induced by cAMP-dependent protein kinase (PKA) signaling - Termination depends on PKA inactivation rather than PKA export from the nucleus | 0 | 0 |
| 157 | 1 | 55 | 157 2005 JOURNAL OF BIOLOGICAL CHEMISTRY 280 (5): 3946-3953 Yang WD; Wang QD; Howell KL; Lee JT; Cho DSC; et al. ADAR1 RNA deaminase limits short interfering RNA efficacy in mammalian cells | 0 | 0 |
| 158 | 1 | 29 | 158 2005 JOURNAL OF BIOLOGICAL CHEMISTRY 280 (7): 5533-5541 Yin LH; Bennani-Baiti N; Powell CT Phorbol ester-induced apoptosis of C4-2 cells requires both a unique and a redundant protein kinase C signaling pathway | 0 | 0 |
| 159 | 1 | 28 | 159 2005 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 90 (2): 1149-1155 Weber F; Aldred MA; Morrison CD; Plass C; Frilling A; et al. Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis | 0 | 0 |
| 160 | 1 | 47 | 160 2005 JOURNAL OF EXPERIMENTAL MEDICINE 201 (4): 603-614 Mandal M; Borowski C; Palomero T; Ferrando AA; Oberdoerffer P; et al. The BCL2A1 gene as a pre-T cell receptorinduced regulator of thymocyte survival | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 161 | 1 | 36 | 161 2005 JOURNAL OF GENE MEDICINE 7 (2): 198-207 Hassani Z; Lemkine GF; Erbacher P; Palmier K; Alfama G; et al. Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels | 0 | 0 |
| 162 | 1 | 66 | 162 2005 JOURNAL OF IMMUNOLOGY 174 (6): 3369-3376 Mizuno T; Rothstein TL B cell receptor (BCR) cross-talk: CD40 engagement enhances BCR-induced ERK activation | 0 | 0 |
| 163 | 1 | 59 | 163 2005 JOURNAL OF IMMUNOLOGY 174 (6): 3719-3726 Rivieccio MA; John GR; Song XY; Suh HS; Zhao YM; et al. The cytokine IL-1 beta activates IFN response factor 3 in human fetal astrocytes in culture | 0 | 0 |
| 164 | 3 | 67 | 164 2005 JOURNAL OF THEORETICAL BIOLOGY 233 (3): 301-314 Bahramian MB; Zarbl H GENE impedance: a natural process for control of gene expression and the origin of RNA interference | 0 | 0 |
| 165 | 3 | 72 | 165 2005 JOURNAL OF VIROLOGY 79 (3): 1645-1654 Leonard JN; Schaffer DV Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape | 0 | 0 |
| 166 | 2 | 39 | 166 2005 LIVER INTERNATIONAL 25 (1): 9-15 Arbuthnot P; Carmona S; Ely A Exploiting the RNA interference pathway to counter hepatitis B virus replication | 0 | 0 |
| 167 | 1 | 35 | 167 2005 MOLECULAR & CELLULAR PROTEOMICS 4 (1): 44-55 Machuy N; Thiede B; Rajalingam K; Dimmler C; Thieck O; et al. A global approach combining proteome analysis and phenotypic screening with RNA interference yields novel apoptosis regulators | 0 | 0 |
| 168 | 3 | 56 | 168 2005 MOLECULAR CELL 17 (1): 1-10 Huppi K; Martin SE; Caplen NJ Defining and assaying RNAi in mammalian cells | 0 | 0 |
| 169 | 5 | 11 | 169 2005 NATURE BIOTECHNOLOGY 23 (2): 181-182 Williams BRG Dicing with siRNA | 0 | 0 |
| 170 | 4 | 45 | 170 2005 NATURE MEDICINE 11 (1): 50-55 Bitko V; Musiyenko A; Shulyayeva O; Barik S Inhibition of respiratory viruses by nasally administered siRNA | 1 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 171 | 2 | 48 | 171 2005 NATURE MEDICINE 11 (1): 56-62 Zhang WD; Yang H; Kong XY; Mohapatra S; San Juan-Vergara H; et al. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene | 0 | 1 |
| 172 | 6 | 14 | 172 2005 NATURE MEDICINE 11 (3): 250-251 Robbins MA; Rossi JJ Sensing the danger in RNA | 0 | 0 |
| 173 | 3 | 47 | 173 2005 NATURE MEDICINE 11 (3): 263-270 Hornung V; Guenthner-Biller M; Bourquin C; Ablasser A; Schlee M; et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7 | 1 | 1 |
| 174 | 1 | 66 | 174 2005 NATURE METHODS 2 (1): 17-25 Johnson SA; Hunter T Kinomics: methods for deciphering the kinome | 0 | 0 |
| 175 | 1 | 4 | 175 2005 NATURE METHODS 2 (4): 241-241 Fedorov Y; King A; Anderson E; Karpilow J; Ilsley D; et al. Different delivery methods - different expression profiles | 0 | 0 |
| 176 | 2 | 30 | 176 2005 NUCLEIC ACIDS RESEARCH 33 (4): 1240-1248 Bergeron LJ; Perreault JP Target-dependent on/off switch increases ribozyme fidelity | 0 | 0 |
| 177 | 1 | 59 | 177 2005 ONCOGENE 24 (4): 605-615 Porta C; Hadj-Slimane R; Nejmeddine M; Pampin M; Tovey MG; et al. Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively | 0 | 0 |
| 178 | 2 | 11 | 178 2005 PHARMACOGENOMICS 6 (1): 1-4 Samarsky DA; Welch PJ RNAi specificity: how big of an issue is it? | 0 | 0 |
| 179 | 5 | 41 | 179 2005 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 102 (7): 2396-2401 Kittler R; Pelletier L; Ma CL; Poser I; Fischer S; et al. RNA interference rescue by bacterial artificial chromosome transgenesis in mammalian tissue culture cells | 0 | 0 |
| 180 | 2 | 36 | 180 2005 RNA-A PUBLICATION OF THE RNA SOCIETY 11 (1): 38-44 Gu S; Rossi JJ Uncoupling of RNAi from active translation in mammalian cells | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 181 | 3 | 27 | 181 2005 TRENDS IN IMMUNOLOGY 26 (2): 65-68 Grubman MJ; de los Santos T Rapid control of foot-and-mouth disease outbreaks: is RNAi a possible solution? | 0 | 0 |
| 182 | 2 | 69 | 182 2005 TRENDS IN MOLECULAR MEDICINE 11 (3): 104-113 Lu PY; Xie FY; Woodle MC Modulation of angiogenesis with siRNA inhibitors for novel therapeutics | 0 | 0 |
Generated by: HistCite 2005.04.07